Here we demonstrate that subcutaneous administration of an ENPP1-Fc fusion protein prevents the mortality, vascular calcifications and sequela of disease in animal models of GACI, and is accompanied by a complete clinical and biomarker response. This evidence concerns the gene ENPP1 and arterial calcification, generalized, of infancy, 1.